Surfer rescued after getting into difficulty off west Cork coast Young man ‘plucked him from the choppy seas’ by RNLI crew on Saturday afternoon
Sun, Jan 31, 2021, 10:35
A surfer was rescued on Saturday afternoon after getting into difficulty off the west Cork coast.
The young man was in difficulty for almost 45 minutes about 1km offshore at Garrylucas Beach near the Old Head of Kinsale shortly after 4pm.
Courtmacsherry RNLI Voluntary Lifeboat Operations Manager, Brian O Dwyer said a lifeboat was launched within minutes.
“They proceeded at full speed to the area where the casualty was and they arrived there within 15 minutes – there was a rough sea and the casualty was being blown out to sea,” said Mr O’Dwyer.
VALENTINES DAY: Zoos are raising funds by letting YOU name roaches, rats and other creepy animals in honor of EX LOVERS for Valentine's Day! Here's who's getting in on the action now.
VALENTINES DAY: Zoos are raising funds by letting YOU name roaches, rats and other creepy animals in honor of EX LOVERS for Valentine's Day! Here's who's getting in on the action now.
UK study finds antibiotics azithromycin and doxycycline ineffective against COVID-19
PRINCIPLE study evaluated the commonly-used antibiotics in patients aged over 50
The UK-based PRINCIPLE study has found that the commonly-used antibiotics azithromycin and doxycycline are not generally effective in certain patients with early COVID-19.
The study evaluated each antibiotic as separate treatments in the trial – although interim data has found that neither drug reduced the time to self-reported recovery in patients aged over 50 years.
For the 526 patients randomised to receive azithromycin, the estimated median time to self-reported recover was 0.94 days shorter compared to standard care after 28 days of follow-up.
There was also no evidence that azithromycin reduced COVID-19-associated hospitalisations or death compared with standard care.
F. Hoffmann-La Roche Ltd: Roche renews partnership with Sysmex to deliver haematology testing solutions
This successful long-running partnership continues to evolve and bring haematology testing innovations to laboratories, globally
The new agreement aims to utilise the IT systems to lead to improved clinical decision making and customer experience
Blood disorders have a high impact, not only for patients but for society as a whole, accounting for a third of all central laboratory tests
1
Basel, 25 January 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that, on 14 December, 2020, it signed a Global Business Partnership Agreement (GBP) with Sysmex. Under this new framework, the parties renewed their commitment to the long standing Distribution, Sales and Service (DSS) agreement, allowing Roche to continue to distribute Sysmex haematology products, including instruments and reagents.